Bleeding risk for patients with haemophilia under antithrombotic therapy. Results of the French multicentric study ERHEA.

Authors :: Desjonqueres A
Guillet B
Beurrier P
Pan-Petesch B
Ardillon L
Pineau-Vincent F
Sigaud M
Fouassier M
Ternisien C
Gillet B
Béné MC
Horvais V
Lienhart A
Trossaërt M
Source :: British journal of haematology [Br J Haematol] 2019 May; Vol. 185 (4), pp. 764-767. Date of Electronic Publication: 2018 Oct 18.
Publication Year :: 2019

Subjects :: Aged
Aged, 80 and over
Case-Control Studies
Factor IX metabolism
Factor VIII metabolism
Humans
Middle Aged
Risk Factors
Cardiovascular Diseases drug therapy
Fibrinolytic Agents adverse effects
Hemophilia A complications
Hemorrhage chemically induced

Full Text Access

Tools